Replies to post #22823 on Omni Health Inc (OMHE)

[BubbaInSC]

I Wasn't Able to communicate with him, and no emails returned at all. Many others have experienced the same. You'd be the first person who has allegedly spoken with him.

As to "going forward" proof is in the pudding, if you know what I mean.

There has been little communication, and little substance.

I know if I were running the company, I would put out transparent press releases on a regular basis; and more importantly, execute on those forward looking statements.

So, when the latest PR says "getting ready for NASDAQ uplist"; which again, was recycled from 1.5 years ago - it's hard to believe OMHE is going to change their stripes. It's the same ol' bait and no execute MO that has been exhibited for the past 1.5 years.

Again $0 revenues from AmeriMark and MediCann. That says a lot right there.

[BubbaInSC]

Claw Any Thoughts About The Following?

This was before any further announcements from OMHE re: AmeriMark and MediCann.

6/13/17
Official OMHE PR From 6/13/17

MIAMI, FL--(Marketwired - Jun 13, 2017) - Omni Health, Inc., ( OTC PINK : OMHE ), a vertically integrated healthcare company with focus on pharmaceutical, anti-aging products, and cannabis biotech engineering, announced today the roll out of Celeb Cream, anti-aging product line. Dr. Lawrence Samuels, a member of the Scientific Advisory Board of OMHE, was the scientific engineer of the Celeb Cream original products. Celeb Cream is an all-in-one anti-aging complex with the most effective peptides clinically proven to reduce appearance of wrinkles. For more information on Celeb Cream visit www.celebcream.com.

Celeb Cream, Inc., expects to bring more than $2M in revenue to OMHE over the course of the next year, increasing OMHE projections for this fiscal year to more than $10M in revenue.